Paul J. Gil, PhD Amicus Therapeutics, Inc.

Paul Gil has 30+ years of industry experience in Regulatory CMC, including 17 years with Bayer Healthcare and Viropharma/Shire. Most recently he has led Reg CMC teams in the gene therapy area from the IND phase through licensure. He is currently Executive Director Global Regulatory Affairs CMC at Amicus Therapeutics, a company with many gene therapy products in clinical trials.